3652 results for «378»

Filter By

3652 results

Nightmares in TAVI: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

18 Feb 2024 – From PCR Tokyo Valves 2024

This session of rapid-fire submitted cases focuses on transcatheter interventions for tailed mitral valve prosthesis. Learn about unusual solutions, such a reversed loop and parallel wiring to close crescent mitral paravalvular leak, base-to-tip LAMPOON and IABP during a successful mitral valve-in-valve, and more!

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

Rapid-fire - Pulmonary and tricuspid valve implantation

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.

Rapid-fire - Pulmonary and tricuspid valve implantation

Managing aortic stenosis in patients with longer life expectancy

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.

Tricuspid valve interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.

Tricuspid valve interventions

Imaging for aortic valve disease

18 Feb 2024 – From PCR Tokyo Valves 2024

Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...

Rapid-fire - Bailout in SHD

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Distal radial approach to reaccess and recanalize the occluded radial artery

30 Apr 2021

A 56-year-old man was re-admitted with chest pain. He had been hospitalized 2 weeks before because of MI, was suffering from metastatic carcinoma with recurrent PTE, and was on long-term subcutaneous heparin...

Distal radial approach to reaccess and recanalize the occluded radial artery

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

02 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan
Ali Nazmi Calik

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?